{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(2)"],"submitter":["Zhao Z"],"pubmed_abstract":["<h4>Introduction</h4>Qishenbuqi capsule (QSBQC), a listed Chinese patent prescription, comprises of 4 herbs. Clinically, it has been shown to improve immune functions.<h4>Methods</h4>Subjects with <i>Qi</i> deficiency and non-<i>Qi</i> deficiency were recruited, who then took QSBQC for 4 weeks. Traditional Chinese medicine (TCM) syndrome scores and the levels of white blood cells, CD3<sup>+</sup> T cells (CD3<sup>+</sup>), CD4<sup>+</sup> T cells (CD3<sup>+</sup>CD4<sup>+</sup>), CD8<sup>+</sup> T cells (CD3<sup>+</sup>CD8<sup>+</sup>), and CD4<sup>+</sup>/CD8<sup>+</sup> were determined. Serum metabolomics was used to explore the metabolic mechanisms of QSBQC on improving immunity. Meanwhile, the potential active ingredients, targets, and pathways of QSBQC on enhancing immunity were scree"],"journal":["Toxicology research"],"pagination":["201-215"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10141780"],"repository":["biostudies-literature"],"pubmed_title":["Integration of serum metabolomics and network pharmacology reveals the immunoenhancing mechanisms of Qishenbuqi capsules."],"pmcid":["PMC10141780"],"pubmed_authors":["Fan Y","Yang L","Zhao R","Cui Y","Liu XJ","Qin X","Xu S","Ji J","Zhao Z","Wu Y","Yuan Y","Zhang P"],"additional_accession":[]},"is_claimable":false,"name":"Integration of serum metabolomics and network pharmacology reveals the immunoenhancing mechanisms of Qishenbuqi capsules.","description":"<h4>Introduction</h4>Qishenbuqi capsule (QSBQC), a listed Chinese patent prescription, comprises of 4 herbs. Clinically, it has been shown to improve immune functions.<h4>Methods</h4>Subjects with <i>Qi</i> deficiency and non-<i>Qi</i> deficiency were recruited, who then took QSBQC for 4 weeks. Traditional Chinese medicine (TCM) syndrome scores and the levels of white blood cells, CD3<sup>+</sup> T cells (CD3<sup>+</sup>), CD4<sup>+</sup> T cells (CD3<sup>+</sup>CD4<sup>+</sup>), CD8<sup>+</sup> T cells (CD3<sup>+</sup>CD8<sup>+</sup>), and CD4<sup>+</sup>/CD8<sup>+</sup> were determined. Serum metabolomics was used to explore the metabolic mechanisms of QSBQC on improving immunity. Meanwhile, the potential active ingredients, targets, and pathways of QSBQC on enhancing immunity were scree","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2025-04-18T20:57:36.372Z","creation":"2025-04-07T09:02:30.814Z"},"accession":"S-EPMC10141780","cross_references":{"pubmed":["37125330"],"doi":["10.1093/toxres/tfad008"]}}